Graphen Drugomics, Inc
- Biotech or pharma, therapeutic R&D
- Digital health
In-house pipelines include DMOAD for Osteoarthritis, and first-in-class duel-target compounds in difficult to treat cancers.
Graphen Drugomics is an AI-driven drug design and development company, targeting on novel or existing targets for small molecules through in-house or co-development effort.